Hormonsensitiver, metastasierter Prostatakrebs: PSA-Antwort auf Abirateronacetat gibt Hinweise auf Prognose
Original Titel: Correlation of Prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen Deprivation Therapy: Post Hoc Analysis of Phase 3 LATITUDE Study…
Mehr Lesen